Product Description
Lafutidine (INN) is a second generation histamine H2 receptor antagonist having multimodal mechanism of action and used to treat gastrointestinal disorders.
Lafutidine is used to treat gastric ulcers, duodenal ulcers, as well as wounds in the lining of the stomach associated with acute gastritis and acute exacerbation of chronic gastritis.
High-Quality Medicine Grade LafutidineOur Lafutidine API stands out with its remarkable purity of 99%, ensuring safety and efficacy for medicinal use. Designed for use as a pharmaceutical intermediate, it meets rigorous industry standards, making it a preferred choice for manufacturers of gastrointestinal treatments worldwide. Its stable powder form and five-year shelf life allow for flexible handling and storage, supporting consistent production workflows.
Advanced Pharmaceutical ApplicationsLafutidine's advantage lies in its multimodal mechanism as a second-generation histamine H2 receptor antagonist. Its primary use is in the treatment of gastrointestinal disorders, offering multiple pathways to alleviate symptoms and promote healing. Provided as a versatile, easily handled powder, Lafutidine is reliable for various pharmaceutical formulation needs.
FAQ's of Lafutidine Api:
Q: How is Lafutidine API commonly used in pharmaceutical manufacturing?
A: Lafutidine API is utilized as a key intermediate in the production of medications targeting gastrointestinal disorders. Its high purity and stability make it an essential ingredient for formulating effective second-generation H2 receptor antagonist drugs.
Q: What benefits does Lafutidine offer over first-generation H2 receptor antagonists?
A: Lafutidine provides a multimodal mechanism of action, which enhances its effectiveness in treating gastrointestinal issues. This second-generation compound is more targeted and efficient compared to earlier H2 antagonists, potentially resulting in improved patient outcomes.
Q: When should Lafutidine API be considered for use in pharmaceutical formulations?
A: Pharmaceutical companies should consider Lafutidine API when developing or manufacturing medications for gastrointestinal disorders where a potent and long-lasting H2 antagonist is required. Its extended shelf life also allows for flexible procurement and stock management.
Q: Where is Lafutidine API produced and supplied from?
A: This pharmaceutical intermediate is produced, exported, and supplied by reliable traders and manufacturers based in India, offering global distribution to pharmaceutical companies.
Q: What is the process for handling and storing Lafutidine API?
A: Lafutidine is delivered as a white or almost white powder, requiring storage in cool, dry conditions away from direct sunlight. Proper handling procedures ensure that its medicinal properties and 99% purity are maintained throughout its five-year shelf life.
Q: What is the main usage of Lafutidine in medicine?
A: Lafutidine is mainly used to formulate drugs that treat gastrointestinal disorders by inhibiting histamine H2 receptors, thereby reducing gastric acid secretion and promoting gastrointestinal healing.